How this article was researched

Audited accounts, official filings, regulator material and attributed reporting were separated by evidential status. No valuation was produced.

Commercial status: There are no affiliate links in this edition. Zilch and its advisers did not pay for inclusion or approve this copy.

A possible flotation would create more disclosure; it does not yet settle whether Zilch is profitable or whether its consumer terms have changed. The useful distinction is between reported adviser activity, filed corporate evidence and the terms a borrower sees today.

The Financial Times reported on 30 September 2026 that Zilch had invited banks to pitch for roles in a possible IPO the following year. The article is credible reporting, but it is not a prospectus, admission document or company confirmation of a completed listing. Until one of those documents appears, the event remains preparation for a possible transaction.

The filing is the next evidence threshold

Companies House showed a confirmation statement filed on 4 August 2026, while the latest annual accounts listed for Zilch Technology Limited were made up to 31 March 2025. No IPO prospectus appears in that company filing history. That absence does not prove that adviser discussions stopped; it means the public record retrieved on 21 October does not let a reader audit the reported timetable, offer size or valuation.

A future prospectus would normally provide a more current operating period, principal risks, ownership, use of proceeds and the chosen listing venue. Those fields matter more than a headline valuation. Record the filing date and accounting period before comparing any later figure with the 2025 report.

Do not treat the words “taps banks” as an appointed syndicate or a completed mandate unless the source says so. Adviser selection, formal appointment, filing, price range and admission are separate events. Each can be delayed or abandoned.

Audited growth still ended in a loss

Zilch's audited report for the year ended 31 March 2025 recorded £110.3 million of revenue, £54.5 million of gross profit and a £10.5 million loss after tax. It also recorded a £27.4 million provision for credit losses and £62.3 million of cash at year-end. These figures describe FY2025; they are not current-quarter results.

The loss narrowed from the prior year, while revenue and gross profit increased. That is evidence of improving reported economics, but not evidence that the group had reached net profitability. A loss after tax remains a loss. The next accounts need to show whether the improvement continued and what happened to credit losses, funding costs and customer acquisition spending.

Revenue alone cannot answer the durability question. Zilch's report separates credit, feature, transaction and advertising revenue. A reader comparing this model with a pure lender should identify which revenue scales with borrowing, which depends on merchant or advertising activity, and which costs rise when credit use grows.

The credit-loss provision is particularly relevant. It rose with the expanding receivables book in FY2025. That does not diagnose future losses, but it shows why gross merchandise value or registered users cannot substitute for net income, cash generation and cohort performance.

Regulation changes the evidence, not the arithmetic

The FCA began regulating third-party deferred-payment credit on 15 July 2026. Its firm guidance says fully authorised firms must supply product-sales data so the regulator can supervise the market and customer outcomes. Regulation therefore creates a stronger reporting and conduct framework; it does not guarantee that every transaction is affordable or that a provider is profitable.

For a consumer, the immediate questions remain the payment dates, total charges, missed-payment consequences and complaint route in the actual agreement. A corporate listing does not improve an individual's eligibility. It also does not change a payment schedule unless the provider changes the product and tells customers.

For an investor or market reader, regulation may change compliance costs, approval processes, data obligations and product design. Those effects should be measured in filed results rather than assumed. A prospectus may eventually explain them, but no such filing was verified for this edition.

Use a four-part evidence table

First, label the event. “Reported adviser pitch” is accurate for the 30 September story. “Filed IPO” or “confirmed listing” would overstate the evidence currently available.

Second, record the accounting period. The audited numbers above end on 31 March 2025. A newer management statement may be informative, but it should not be silently combined with audited accounts.

Third, separate operating measures. Put revenue, gross profit, provision for credit losses, funding cost, operating cash flow and loss after tax on different rows. A rise in one does not imply the same direction in the others.

Fourth, keep the consumer contract separate. Product fees, repayment dates and approval criteria belong to the current agreement. They are not derived from an IPO timetable or an analyst's valuation.

What would change the conclusion

A filed prospectus, appointed advisers confirmed by the company, or newer audited accounts would materially improve the evidence. A prospectus could also reveal whether the listing raises primary capital for the company, sells existing shareholders' stock, or combines both. Those are different transactions.

Until then, the defensible conclusion is narrow. Zilch reported strong FY2025 revenue and gross-profit growth while still recording a £10.5 million loss after tax. A possible 2027 IPO was reported, but a listing and its terms were not verified.

If you use BNPL, compare the actual repayment schedule with paying by debit, waiting or using a card you already hold. If you are tracking the company, save the Companies House page and wait for the next accounts or formal filing. That document—not the adviser headline—should settle the next update.

From comparison to calculation

Check the terms in the offer you actually receive.

Credit Over Debt’s Offer X-Ray compares the amount financed, fees, payment schedule and modeled cost using the figures you enter.

Open the free toolkit

Primary sources and product pages

Product details last checked Oct 28, 2026; next scheduled review Nov 27, 2026. This UK-focused guide is educational information, not individualized financial, legal or tax advice. Product terms, offers and eligibility can change.